UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study

Annals of oncology, 2017-03, Vol.28 (3), p.528-534

2017

Volltextzugriff (PDF)

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

Annals of oncology, 2020-06, Vol.31 (6), p.798-806

2020

Volltextzugriff (PDF)

Association of hospital-diagnosed sleep disorders with suicide: a nationwide cohort study

European psychiatry, 2022-06, Vol.65 (S1), p.S123-S124

2022

Volltextzugriff (PDF)

The association between melatonin and suicide: a nationwide cohort study

European psychiatry, 2022-06, Vol.65 (S1), p.S843-S843

2022

Volltextzugriff (PDF)

The association between benzodiazepine and non-benzodiazepine and suicide: a nationwide cohort study

European psychiatry, 2022-06, Vol.65 (S1), p.S181-S181

2022

Volltextzugriff (PDF)

Transcriptomic changes in the nasal epithelium associated with diesel engine exhaust exposure

Environment international, 2020-04, Vol.137, p.105506-105506, Article 105506

2020

Volltextzugriff (PDF)

A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

Annals of oncology, 2015-03, Vol.26 (3), p.556-561

2015

Volltextzugriff (PDF)

Quality of Life and Mental Health in Older Adults with Obesity and Frailty: Associations with a Weight Loss Intervention

The Journal of nutrition, health & aging, 2018-12, Vol.22 (10), p.1259-1265

2018

Volltextzugriff (PDF)

Emotional avoidance: an experimental test of individual differences and response suppression using biological challenge

Behaviour research and therapy, 2003-04, Vol.41 (4), p.403-411

2003

Volltextzugriff (PDF)

Prediabetes and deprivation: A couple at high risk of diabetes

Revue d'épidémiologie et de santé publique, 2021-11, Vol.69 (6), p.361-365

2021

Volltextzugriff (PDF)

Reliability and validity of the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale in older men

The journals of gerontology. Series A, Biological sciences and medical sciences, 2012-04, Vol.67 (4), p.433-439

2012

Volltextzugriff (PDF)

A Short- Time Beltrami Kernel for Smoothing Images and Manifolds

IEEE transactions on image processing, 2007-06, Vol.16 (6), p.1628-1636

2007

Volltextzugriff (PDF)

Preparing the traveller

The Lancet (British edition), 2003-04, Vol.361 (9366), p.1368-1381

Spira, Alan M

2003

Volltextzugriff (PDF)

Association of sleep characteristics with suicidal ideation and suicide attempt among adults aged 50 and older with depressive symptoms in low- and middle-income countries

Sleep health, 2020-02, Vol.6 (1), p.92-99

2020

Volltextzugriff (PDF)

Phase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii519-viii519

2018

Volltextzugriff (PDF)

Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A

ESMO open, 2022-10, Vol.7 (5), p.100563-100563, Article 100563

2022

Volltextzugriff (PDF)

Stage 2 enrollment complete: Sitravatinib in combination with nivolumab in NSCLC patients progressing on prior checkpoint inhibitor therapy

Annals of oncology, 2018-10, Vol.29, p.viii400-viii401

2018

Volltextzugriff (PDF)

Pilot Phase I/II Personalized Therapy Trial for Metastatic Colorectal Cancer: Evaluating the Feasibility of Protein Pathway Activation Mapping for Stratifying Patients to Therapy with Imatinib and Panitumumab

Journal of proteome research, 2014-06, Vol.13 (6), p.2846-2855

2014

Volltextzugriff (PDF)

Preliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii142-viii143

2018

Volltextzugriff (PDF)

Impact of acute exposure to cigarette smoke on airway gene expression

Physiological genomics, 2018-09, Vol.50 (9), p.705-713

2018

Volltextzugriff (PDF)

PS01.07 Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutant NSCLC: First Disclosure of the Codebreak 100 Primary Analysis

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S61-S61

2021

Volltextzugriff (PDF)

Safety, tolerability, and pharmacokinetics of the OX40 agonist ABBV-368 in patients with advanced solid tumors

Annals of oncology, 2018-10, Vol.29, p.viii409-viii409

2018

Volltextzugriff (PDF)

Association between insomnia symptoms and functional status in U.S. older adults

The journals of gerontology. Series B, Psychological sciences and social sciences, 2014-11, Vol.69 Suppl 1 (Suppl 1), p.S35-S41

2014

Volltextzugriff (PDF)

Safety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii144

2018

Volltextzugriff (PDF)

Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

Annals of oncology, 2018-10, Vol.29, p.viii404-viii405

2018

Volltextzugriff (PDF)

1 – 25 von 5.662

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.653)
Mit Volltextzugriff
(4.321)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(49)
... seit 30 Tagen
(26)

Menü

Weitere Dienste

Einstellungen

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

Association of hospital-diagnosed sleep disorders with suicide: a nationwide cohort study

The association between melatonin and suicide: a nationwide cohort study

The association between benzodiazepine and non-benzodiazepine and suicide: a nationwide cohort study

Transcriptomic changes in the nasal epithelium associated with diesel engine exhaust exposure

A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

Quality of Life and Mental Health in Older Adults with Obesity and Frailty: Associations with a Weight Loss Intervention

Emotional avoidance: an experimental test of individual differences and response suppression using biological challenge

Prediabetes and deprivation: A couple at high risk of diabetes

Reliability and validity of the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale in older men

A Short- Time Beltrami Kernel for Smoothing Images and Manifolds

Preparing the traveller

Association of sleep characteristics with suicidal ideation and suicide attempt among adults aged 50 and older with depressive symptoms in low- and middle-income countries

Phase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC)

Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A

Stage 2 enrollment complete: Sitravatinib in combination with nivolumab in NSCLC patients progressing on prior checkpoint inhibitor therapy

Pilot Phase I/II Personalized Therapy Trial for Metastatic Colorectal Cancer: Evaluating the Feasibility of Protein Pathway Activation Mapping for Stratifying Patients to Therapy with Imatinib and Panitumumab

Preliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors

Impact of acute exposure to cigarette smoke on airway gene expression

PS01.07 Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutant NSCLC: First Disclosure of the Codebreak 100 Primary Analysis

Safety, tolerability, and pharmacokinetics of the OX40 agonist ABBV-368 in patients with advanced solid tumors

Association between insomnia symptoms and functional status in U.S. older adults

Safety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891

Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

Suchergebnisse filtern